Showing results (111-120 of 231) with videos related to

Sort By:
Pageof 24
BMJ Open Diabetes Research & Care|November 20, 2020
Caucasian and Asian difference in role of type 1 diabetes on large-for-gestational-age neonatesYanfang Guo, Rong Luo, Daniel J Corsi, et al.
BMJ Open Diabetes Research & Care|February 23, 2020
Neighborhood walkability and risk of gestational diabetesSimone Kew, Chang Ye, Sadia Mehmood, et al.
Clinical Endocrinology|September 17, 2008
Pre-gravid physical activity and reduced risk of glucose intolerance in pregnancy: the role of insulin sensitivityRavi Retnakaran, Ying Qi, Mathew Sermer, et al.
Diabetes Care|May 21, 2010
Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancyRavi Retnakaran, Ying Qi, Mathew Sermer, et al.
Diabetes, Obesity & Metabolism|May 5, 2020
iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan-L studyNicola Morea, Ravi Retnakaran, Josep Vidal, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 14, 2021
Changes in adiposity mediate the associations of diet quality with insulin sensitivity and beta-cell functionKira Zhi Hua Lai, Zhila Semnani-Azad, Ravi Retnakaran, et al.
Clinical Endocrinology|January 31, 2009
An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normalRavi Retnakaran, Ying Qi, Mathew Sermer, et al.
Diabetes Research and Clinical Practice|February 28, 2026
The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic reviewMichelle Li, Kaylem Sharma, Ji-Eun Chon, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 23, 2025
Gestational diabetes mellitus in twin pregnancies versus singleton pregnancies-A retrospective case-control studyNinna L Larsen, Anna S Koefoed, Ulla Kampmann, et al.
Public Health|November 9, 2025
Cardiovascular impact of the national program of publicly-funded access to dapagliflozin in BrazilGabriella R Natividade, Ravi Retnakaran, Moira K Kapral, et al.
Pageof 24